BackYantai Zhenghai Biotechnology , Ltd. Overview

Yantai Zhenghai Biotechnology , Ltd. Receivables

Yantai Zhenghai Biotechnology , Ltd.'s receivables is $60M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$59.76M
↓ 1.70% YoYΔ $-1.04M vs prior year quarter

Peer trimmed avg / median

Loading

Yantai Zhenghai Biotechnology , Ltd. Receivables History

Loading

Yantai Zhenghai Biotechnology , Ltd. vs. peers: Receivables Comparison

Loading

Yantai Zhenghai Biotechnology , Ltd. Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Yantai Zhenghai Biotechnology , Ltd. (300653.SZ) FAQ

The latest receivables for 300653.SZ is $60M as of September 2026. That compares with $61M in the prior-year period — down 1.7% year over year. Investors often review this figure alongside Yantai Zhenghai Biotechnology , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, 300653.SZ's receivables moved from $61M to $60M — a 1.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Yantai Zhenghai Biotechnology , Ltd.'s operating scale or balance-sheet position.

A receivables figure of $60M for 300653.SZ is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting 300653.SZ's receivables ($60M), review year-over-year change from $61M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Yantai Zhenghai Biotechnology , Ltd.'s receivables against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.